SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma at least partially via up-regulating Wnt3 by activating the AKT/mTOR signaling pathway [17]. The gene discussed is WNT3; the disease is bladder transitional cell carcinoma.